Page 532 - O_Desenvolvimento_do_Autismo
P. 532
RINEHARDT, N.; BRADSHAW, J.; BRERETON, A. e TONGE, B.
“Movement preparation in high-functioning autism and Asperger disorder: a
serial choice reaction time task involving motor reprogramming”. Journal of
Autism and Developmental Disorders 31, 2001, pp. 79-88.
RISCH, N.; SPIKER, D.; LOTSPEICH, L.; NOURI, N.; HINDS, D.;
HALLMAYER, J.; KALAYDJIEVA, L.; MCCAGUE, P.; DIMICELI, S.;
PITTS, T.; NGUYEN, L.; YANG, J.; HARPER, C.; THORPE, D.;
VERMEER, S.; YOUNG, C.; WIESE-SLATER, S.; ROGERS, T.; SALMON,
B.; NICHOLAS, P.; PETERSEN, P. B.; PINGREE, C.; MCMAHON, W.;
WONG, D.; CAVALLI-SFORZA, J. J.; KRAEMER, H. C. e MYERS, R. M.
“A genomic screen of autism: evidence for a multilocus etiology”, American
Journal of Human Genetics 65, 1999, pp. 493-507.
ROBBINS, T. “Integrating the neurobiological and neuropsychological
dimensions of autism”. In: J. Russell (ed.). Autism as an executive disorder.
Oxford: Oxford University Press, 1997, pp. 21-53.
ROBERTS, W.; WEAVER, L.; BRIAN, J.; BRYSON, S.; EMELIANOVA, S.;
GRIFFITHS, A. M.; MACKINNON, B.; YIM, C.; WOLPIN, J. e KOREN, G.
“Repeated doses of porcine secretin in the treatment of autism: a randomized,
placebo-controlled trial”. Pediatrics 107, 2001, E71.
ROBINSON, P.; SCHUTZ, C.; MACCIARDI, F.; WHITE, B. e HOLDEN, J.
“Genetically determined low maternal serum dopamine beta-hydroxylase
levels and the etiology of autism spectrum disorders”. American Journal
Medical Genetics 100, 2001, pp. 30-36.

